Skip to main content
. 2019 Jun 11;9:8481. doi: 10.1038/s41598-019-44834-8

Figure 5.

Figure 5

Ang II increases ER Stress and inflammation, while RAS inhibitors reduce inflammation in human mesenchymal stem cells (HMSC) in vitro: Differentiated HMSCs treated with media (control), Angiotensin II (Ang II (1 nM)), A + T (Ang II & Telmisartan (1 mg/ml)), or Captopril (CAP (1 mg/ml)). ER stress and inflammatory markers were measured. Ang II significantly (p < 0.05) increased ER stress markers (Chop, Atf4, Bip) (A–C) and nuclear factor kappa B inhibitor α (Nfkbiα) which is upregulated by the activation of Nfkb (D). Ang II antagonist Telmisartan significantly (p < 0.05) reduced the Ang II induced ER stress and inflammation (A–D). Common letters indicate no significance. Data is presented as mean ± SEM (n = 3). p < 0.05.